nodes	percent_of_prediction	percent_of_DWPC	metapath
Pramipexole—HTR2A—hindlimb—muscle cancer	0.00274	0.0794	CbGeAlD
Pramipexole—HTR2A—appendage—muscle cancer	0.00235	0.0681	CbGeAlD
Pramipexole—DRD4—testis—muscle cancer	0.00195	0.0564	CbGeAlD
Pramipexole—SLC22A2—renal system—muscle cancer	0.0017	0.0493	CbGeAlD
Pramipexole—DRD3—head—muscle cancer	0.00142	0.0411	CbGeAlD
Pramipexole—DRD5—head—muscle cancer	0.00133	0.0385	CbGeAlD
Pramipexole—SLC22A1—renal system—muscle cancer	0.0012	0.0348	CbGeAlD
Pramipexole—HTR2B—smooth muscle tissue—muscle cancer	0.00115	0.0333	CbGeAlD
Pramipexole—DRD1—head—muscle cancer	0.00101	0.0294	CbGeAlD
Pramipexole—HTR1A—renal system—muscle cancer	0.000992	0.0287	CbGeAlD
Pramipexole—Abdominal discomfort—Methotrexate—muscle cancer	0.00091	0.000942	CcSEcCtD
Pramipexole—Gastrointestinal pain—Vincristine—muscle cancer	0.000909	0.000942	CcSEcCtD
Pramipexole—Confusional state—Etoposide—muscle cancer	0.000908	0.000941	CcSEcCtD
Pramipexole—Cardiac arrest—Doxorubicin—muscle cancer	0.000904	0.000936	CcSEcCtD
Pramipexole—Mood swings—Doxorubicin—muscle cancer	0.000901	0.000933	CcSEcCtD
Pramipexole—Infection—Etoposide—muscle cancer	0.000895	0.000927	CcSEcCtD
Pramipexole—Ataxia—Doxorubicin—muscle cancer	0.000894	0.000926	CcSEcCtD
Pramipexole—Asthenia—Dactinomycin—muscle cancer	0.000893	0.000925	CcSEcCtD
Pramipexole—Dysuria—Methotrexate—muscle cancer	0.000887	0.000919	CcSEcCtD
Pramipexole—Dehydration—Doxorubicin—muscle cancer	0.000884	0.000916	CcSEcCtD
Pramipexole—Thrombocytopenia—Etoposide—muscle cancer	0.000882	0.000914	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Methotrexate—muscle cancer	0.000882	0.000913	CcSEcCtD
Pramipexole—Tachycardia—Etoposide—muscle cancer	0.000879	0.000911	CcSEcCtD
Pramipexole—Body temperature increased—Vincristine—muscle cancer	0.000879	0.000911	CcSEcCtD
Pramipexole—Abdominal pain—Vincristine—muscle cancer	0.000879	0.000911	CcSEcCtD
Pramipexole—Skin disorder—Etoposide—muscle cancer	0.000875	0.000906	CcSEcCtD
Pramipexole—Erectile dysfunction—Methotrexate—muscle cancer	0.000874	0.000905	CcSEcCtD
Pramipexole—Dry skin—Doxorubicin—muscle cancer	0.000871	0.000903	CcSEcCtD
Pramipexole—ADRA2C—renal system—muscle cancer	0.000871	0.0252	CbGeAlD
Pramipexole—Hyperhidrosis—Etoposide—muscle cancer	0.000871	0.000902	CcSEcCtD
Pramipexole—SLC22A1—vagina—muscle cancer	0.00087	0.0252	CbGeAlD
Pramipexole—Abdominal pain upper—Doxorubicin—muscle cancer	0.000868	0.000899	CcSEcCtD
Pramipexole—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000868	0.000899	CcSEcCtD
Pramipexole—Photosensitivity reaction—Methotrexate—muscle cancer	0.000866	0.000897	CcSEcCtD
Pramipexole—Hypokalaemia—Doxorubicin—muscle cancer	0.000865	0.000896	CcSEcCtD
Pramipexole—HTR2B—tendon—muscle cancer	0.000864	0.025	CbGeAlD
Pramipexole—Breast disorder—Doxorubicin—muscle cancer	0.000859	0.00089	CcSEcCtD
Pramipexole—Anorexia—Etoposide—muscle cancer	0.000859	0.000889	CcSEcCtD
Pramipexole—Diarrhoea—Dactinomycin—muscle cancer	0.000852	0.000882	CcSEcCtD
Pramipexole—Pneumonia—Methotrexate—muscle cancer	0.000851	0.000881	CcSEcCtD
Pramipexole—Nasopharyngitis—Doxorubicin—muscle cancer	0.00085	0.000881	CcSEcCtD
Pramipexole—Drowsiness—Methotrexate—muscle cancer	0.000846	0.000876	CcSEcCtD
Pramipexole—Infestation NOS—Methotrexate—muscle cancer	0.000846	0.000876	CcSEcCtD
Pramipexole—Infestation—Methotrexate—muscle cancer	0.000846	0.000876	CcSEcCtD
Pramipexole—Depression—Methotrexate—muscle cancer	0.000844	0.000874	CcSEcCtD
Pramipexole—Hypotension—Etoposide—muscle cancer	0.000842	0.000872	CcSEcCtD
Pramipexole—Gastritis—Doxorubicin—muscle cancer	0.000841	0.000871	CcSEcCtD
Pramipexole—Muscular weakness—Doxorubicin—muscle cancer	0.000839	0.000868	CcSEcCtD
Pramipexole—Renal failure—Methotrexate—muscle cancer	0.000832	0.000861	CcSEcCtD
Pramipexole—Abdominal distension—Doxorubicin—muscle cancer	0.000827	0.000857	CcSEcCtD
Pramipexole—Conjunctivitis—Methotrexate—muscle cancer	0.000822	0.000852	CcSEcCtD
Pramipexole—HTR1B—head—muscle cancer	0.000822	0.0238	CbGeAlD
Pramipexole—Dysphagia—Doxorubicin—muscle cancer	0.000822	0.000851	CcSEcCtD
Pramipexole—Influenza—Doxorubicin—muscle cancer	0.000822	0.000851	CcSEcCtD
Pramipexole—Asthma—Doxorubicin—muscle cancer	0.000822	0.000851	CcSEcCtD
Pramipexole—Hypersensitivity—Vincristine—muscle cancer	0.000819	0.000849	CcSEcCtD
Pramipexole—Sweating—Methotrexate—muscle cancer	0.000811	0.00084	CcSEcCtD
Pramipexole—Paraesthesia—Etoposide—muscle cancer	0.000809	0.000838	CcSEcCtD
Pramipexole—Haematuria—Methotrexate—muscle cancer	0.000807	0.000836	CcSEcCtD
Pramipexole—Pancreatitis—Doxorubicin—muscle cancer	0.000806	0.000834	CcSEcCtD
Pramipexole—SLC22A1—head—muscle cancer	0.000803	0.0233	CbGeAlD
Pramipexole—Dyspnoea—Etoposide—muscle cancer	0.000803	0.000832	CcSEcCtD
Pramipexole—HTR2B—vagina—muscle cancer	0.000802	0.0232	CbGeAlD
Pramipexole—Somnolence—Etoposide—muscle cancer	0.000801	0.00083	CcSEcCtD
Pramipexole—Angina pectoris—Doxorubicin—muscle cancer	0.0008	0.000829	CcSEcCtD
Pramipexole—Hepatobiliary disease—Methotrexate—muscle cancer	0.0008	0.000829	CcSEcCtD
Pramipexole—Epistaxis—Methotrexate—muscle cancer	0.000798	0.000827	CcSEcCtD
Pramipexole—Asthenia—Vincristine—muscle cancer	0.000798	0.000826	CcSEcCtD
Pramipexole—HTR1D—head—muscle cancer	0.000796	0.0231	CbGeAlD
Pramipexole—Vomiting—Dactinomycin—muscle cancer	0.000791	0.00082	CcSEcCtD
Pramipexole—Bronchitis—Doxorubicin—muscle cancer	0.00079	0.000818	CcSEcCtD
Pramipexole—HTR2C—head—muscle cancer	0.000788	0.0228	CbGeAlD
Pramipexole—Rash—Dactinomycin—muscle cancer	0.000785	0.000813	CcSEcCtD
Pramipexole—Decreased appetite—Etoposide—muscle cancer	0.000783	0.000811	CcSEcCtD
Pramipexole—HTR2A—embryo—muscle cancer	0.000781	0.0226	CbGeAlD
Pramipexole—ADRA2C—cardiac atrium—muscle cancer	0.00078	0.0226	CbGeAlD
Pramipexole—Gastrointestinal disorder—Etoposide—muscle cancer	0.000778	0.000806	CcSEcCtD
Pramipexole—Fatigue—Etoposide—muscle cancer	0.000777	0.000805	CcSEcCtD
Pramipexole—Constipation—Etoposide—muscle cancer	0.00077	0.000798	CcSEcCtD
Pramipexole—Pain—Etoposide—muscle cancer	0.00077	0.000798	CcSEcCtD
Pramipexole—Dysuria—Doxorubicin—muscle cancer	0.000768	0.000796	CcSEcCtD
Pramipexole—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.000764	0.000791	CcSEcCtD
Pramipexole—Diarrhoea—Vincristine—muscle cancer	0.000761	0.000788	CcSEcCtD
Pramipexole—Pollakiuria—Doxorubicin—muscle cancer	0.000759	0.000786	CcSEcCtD
Pramipexole—Pharyngitis—Methotrexate—muscle cancer	0.000754	0.000781	CcSEcCtD
Pramipexole—Urinary tract disorder—Methotrexate—muscle cancer	0.00075	0.000777	CcSEcCtD
Pramipexole—Photosensitivity reaction—Doxorubicin—muscle cancer	0.00075	0.000777	CcSEcCtD
Pramipexole—Weight increased—Doxorubicin—muscle cancer	0.000748	0.000775	CcSEcCtD
Pramipexole—Urethral disorder—Methotrexate—muscle cancer	0.000745	0.000771	CcSEcCtD
Pramipexole—Weight decreased—Doxorubicin—muscle cancer	0.000743	0.00077	CcSEcCtD
Pramipexole—Feeling abnormal—Etoposide—muscle cancer	0.000742	0.000769	CcSEcCtD
Pramipexole—Hyperglycaemia—Doxorubicin—muscle cancer	0.000741	0.000768	CcSEcCtD
Pramipexole—HTR2B—head—muscle cancer	0.00074	0.0215	CbGeAlD
Pramipexole—Nausea—Dactinomycin—muscle cancer	0.000739	0.000766	CcSEcCtD
Pramipexole—Pneumonia—Doxorubicin—muscle cancer	0.000737	0.000763	CcSEcCtD
Pramipexole—Gastrointestinal pain—Etoposide—muscle cancer	0.000737	0.000763	CcSEcCtD
Pramipexole—Dizziness—Vincristine—muscle cancer	0.000735	0.000762	CcSEcCtD
Pramipexole—Infestation NOS—Doxorubicin—muscle cancer	0.000733	0.000759	CcSEcCtD
Pramipexole—Infestation—Doxorubicin—muscle cancer	0.000733	0.000759	CcSEcCtD
Pramipexole—Drowsiness—Doxorubicin—muscle cancer	0.000733	0.000759	CcSEcCtD
Pramipexole—Visual impairment—Methotrexate—muscle cancer	0.000732	0.000758	CcSEcCtD
Pramipexole—Renal failure—Doxorubicin—muscle cancer	0.00072	0.000746	CcSEcCtD
Pramipexole—Neuropathy peripheral—Doxorubicin—muscle cancer	0.000718	0.000744	CcSEcCtD
Pramipexole—Urticaria—Etoposide—muscle cancer	0.000716	0.000741	CcSEcCtD
Pramipexole—Abdominal pain—Etoposide—muscle cancer	0.000712	0.000738	CcSEcCtD
Pramipexole—Body temperature increased—Etoposide—muscle cancer	0.000712	0.000738	CcSEcCtD
Pramipexole—Urinary tract infection—Doxorubicin—muscle cancer	0.000712	0.000738	CcSEcCtD
Pramipexole—Conjunctivitis—Doxorubicin—muscle cancer	0.000712	0.000738	CcSEcCtD
Pramipexole—Eye disorder—Methotrexate—muscle cancer	0.00071	0.000735	CcSEcCtD
Pramipexole—Tinnitus—Methotrexate—muscle cancer	0.000708	0.000734	CcSEcCtD
Pramipexole—Vomiting—Vincristine—muscle cancer	0.000707	0.000732	CcSEcCtD
Pramipexole—Cardiac disorder—Methotrexate—muscle cancer	0.000705	0.00073	CcSEcCtD
Pramipexole—Sweating—Doxorubicin—muscle cancer	0.000702	0.000727	CcSEcCtD
Pramipexole—Rash—Vincristine—muscle cancer	0.000701	0.000726	CcSEcCtD
Pramipexole—Dermatitis—Vincristine—muscle cancer	0.000701	0.000726	CcSEcCtD
Pramipexole—Haematuria—Doxorubicin—muscle cancer	0.000699	0.000724	CcSEcCtD
Pramipexole—Headache—Vincristine—muscle cancer	0.000697	0.000722	CcSEcCtD
Pramipexole—Hepatobiliary disease—Doxorubicin—muscle cancer	0.000693	0.000718	CcSEcCtD
Pramipexole—Epistaxis—Doxorubicin—muscle cancer	0.000691	0.000716	CcSEcCtD
Pramipexole—Angiopathy—Methotrexate—muscle cancer	0.000689	0.000714	CcSEcCtD
Pramipexole—Sinusitis—Doxorubicin—muscle cancer	0.000687	0.000712	CcSEcCtD
Pramipexole—Immune system disorder—Methotrexate—muscle cancer	0.000686	0.000711	CcSEcCtD
Pramipexole—Mediastinal disorder—Methotrexate—muscle cancer	0.000685	0.000709	CcSEcCtD
Pramipexole—Chills—Methotrexate—muscle cancer	0.000682	0.000706	CcSEcCtD
Pramipexole—ADRA2C—tendon—muscle cancer	0.00068	0.0197	CbGeAlD
Pramipexole—Alopecia—Methotrexate—muscle cancer	0.000671	0.000695	CcSEcCtD
Pramipexole—Bradycardia—Doxorubicin—muscle cancer	0.00067	0.000694	CcSEcCtD
Pramipexole—Mental disorder—Methotrexate—muscle cancer	0.000665	0.000689	CcSEcCtD
Pramipexole—Hypersensitivity—Etoposide—muscle cancer	0.000664	0.000687	CcSEcCtD
Pramipexole—HTR1A—head—muscle cancer	0.000663	0.0192	CbGeAlD
Pramipexole—Erythema—Methotrexate—muscle cancer	0.000661	0.000685	CcSEcCtD
Pramipexole—Malnutrition—Methotrexate—muscle cancer	0.000661	0.000685	CcSEcCtD
Pramipexole—Nausea—Vincristine—muscle cancer	0.000661	0.000684	CcSEcCtD
Pramipexole—Rhinitis—Doxorubicin—muscle cancer	0.000659	0.000683	CcSEcCtD
Pramipexole—Hypoaesthesia—Doxorubicin—muscle cancer	0.000654	0.000678	CcSEcCtD
Pramipexole—Pharyngitis—Doxorubicin—muscle cancer	0.000653	0.000676	CcSEcCtD
Pramipexole—Urinary tract disorder—Doxorubicin—muscle cancer	0.00065	0.000673	CcSEcCtD
Pramipexole—Oedema peripheral—Doxorubicin—muscle cancer	0.000648	0.000671	CcSEcCtD
Pramipexole—Dysgeusia—Methotrexate—muscle cancer	0.000648	0.000671	CcSEcCtD
Pramipexole—Asthenia—Etoposide—muscle cancer	0.000646	0.000669	CcSEcCtD
Pramipexole—Connective tissue disorder—Doxorubicin—muscle cancer	0.000646	0.000669	CcSEcCtD
Pramipexole—Urethral disorder—Doxorubicin—muscle cancer	0.000645	0.000668	CcSEcCtD
Pramipexole—Back pain—Methotrexate—muscle cancer	0.00064	0.000662	CcSEcCtD
Pramipexole—Pruritus—Etoposide—muscle cancer	0.000637	0.00066	CcSEcCtD
Pramipexole—Visual impairment—Doxorubicin—muscle cancer	0.000634	0.000656	CcSEcCtD
Pramipexole—ADRA2C—vagina—muscle cancer	0.000631	0.0183	CbGeAlD
Pramipexole—Vision blurred—Methotrexate—muscle cancer	0.000623	0.000645	CcSEcCtD
Pramipexole—ADRA2A—cardiac atrium—muscle cancer	0.000622	0.018	CbGeAlD
Pramipexole—Diarrhoea—Etoposide—muscle cancer	0.000616	0.000638	CcSEcCtD
Pramipexole—Eye disorder—Doxorubicin—muscle cancer	0.000615	0.000637	CcSEcCtD
Pramipexole—HTR2A—smooth muscle tissue—muscle cancer	0.000614	0.0178	CbGeAlD
Pramipexole—Ill-defined disorder—Methotrexate—muscle cancer	0.000614	0.000635	CcSEcCtD
Pramipexole—Tinnitus—Doxorubicin—muscle cancer	0.000613	0.000635	CcSEcCtD
Pramipexole—Anaemia—Methotrexate—muscle cancer	0.000611	0.000633	CcSEcCtD
Pramipexole—Cardiac disorder—Doxorubicin—muscle cancer	0.00061	0.000632	CcSEcCtD
Pramipexole—Flushing—Doxorubicin—muscle cancer	0.00061	0.000632	CcSEcCtD
Pramipexole—DRD2—head—muscle cancer	0.000599	0.0174	CbGeAlD
Pramipexole—Angiopathy—Doxorubicin—muscle cancer	0.000597	0.000618	CcSEcCtD
Pramipexole—Malaise—Methotrexate—muscle cancer	0.000596	0.000618	CcSEcCtD
Pramipexole—Dizziness—Etoposide—muscle cancer	0.000596	0.000617	CcSEcCtD
Pramipexole—Immune system disorder—Doxorubicin—muscle cancer	0.000594	0.000615	CcSEcCtD
Pramipexole—Vertigo—Methotrexate—muscle cancer	0.000594	0.000615	CcSEcCtD
Pramipexole—Mediastinal disorder—Doxorubicin—muscle cancer	0.000593	0.000614	CcSEcCtD
Pramipexole—Leukopenia—Methotrexate—muscle cancer	0.000592	0.000613	CcSEcCtD
Pramipexole—HTR2A—renal system—muscle cancer	0.000591	0.0171	CbGeAlD
Pramipexole—Chills—Doxorubicin—muscle cancer	0.00059	0.000611	CcSEcCtD
Pramipexole—ADRA2C—head—muscle cancer	0.000583	0.0169	CbGeAlD
Pramipexole—Alopecia—Doxorubicin—muscle cancer	0.000581	0.000602	CcSEcCtD
Pramipexole—DRD2—testis—muscle cancer	0.000579	0.0168	CbGeAlD
Pramipexole—Cough—Methotrexate—muscle cancer	0.000577	0.000598	CcSEcCtD
Pramipexole—Mental disorder—Doxorubicin—muscle cancer	0.000576	0.000597	CcSEcCtD
Pramipexole—Convulsion—Methotrexate—muscle cancer	0.000573	0.000593	CcSEcCtD
Pramipexole—Vomiting—Etoposide—muscle cancer	0.000573	0.000593	CcSEcCtD
Pramipexole—Erythema—Doxorubicin—muscle cancer	0.000573	0.000593	CcSEcCtD
Pramipexole—Malnutrition—Doxorubicin—muscle cancer	0.000573	0.000593	CcSEcCtD
Pramipexole—Rash—Etoposide—muscle cancer	0.000568	0.000588	CcSEcCtD
Pramipexole—Dermatitis—Etoposide—muscle cancer	0.000568	0.000588	CcSEcCtD
Pramipexole—Headache—Etoposide—muscle cancer	0.000564	0.000585	CcSEcCtD
Pramipexole—Flatulence—Doxorubicin—muscle cancer	0.000564	0.000584	CcSEcCtD
Pramipexole—ADRA2C—testis—muscle cancer	0.000563	0.0163	CbGeAlD
Pramipexole—Chest pain—Methotrexate—muscle cancer	0.000563	0.000583	CcSEcCtD
Pramipexole—Myalgia—Methotrexate—muscle cancer	0.000563	0.000583	CcSEcCtD
Pramipexole—Arthralgia—Methotrexate—muscle cancer	0.000563	0.000583	CcSEcCtD
Pramipexole—Tension—Doxorubicin—muscle cancer	0.000562	0.000582	CcSEcCtD
Pramipexole—Dysgeusia—Doxorubicin—muscle cancer	0.000561	0.000581	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000559	0.000579	CcSEcCtD
Pramipexole—Discomfort—Methotrexate—muscle cancer	0.000556	0.000576	CcSEcCtD
Pramipexole—Nervousness—Doxorubicin—muscle cancer	0.000556	0.000576	CcSEcCtD
Pramipexole—Back pain—Doxorubicin—muscle cancer	0.000554	0.000574	CcSEcCtD
Pramipexole—Muscle spasms—Doxorubicin—muscle cancer	0.00055	0.00057	CcSEcCtD
Pramipexole—Confusional state—Methotrexate—muscle cancer	0.000544	0.000564	CcSEcCtD
Pramipexole—ADRA2A—tendon—muscle cancer	0.000542	0.0157	CbGeAlD
Pramipexole—Vision blurred—Doxorubicin—muscle cancer	0.00054	0.000559	CcSEcCtD
Pramipexole—Infection—Methotrexate—muscle cancer	0.000536	0.000555	CcSEcCtD
Pramipexole—Nausea—Etoposide—muscle cancer	0.000535	0.000554	CcSEcCtD
Pramipexole—Ill-defined disorder—Doxorubicin—muscle cancer	0.000531	0.00055	CcSEcCtD
Pramipexole—Nervous system disorder—Methotrexate—muscle cancer	0.000529	0.000548	CcSEcCtD
Pramipexole—Anaemia—Doxorubicin—muscle cancer	0.000529	0.000548	CcSEcCtD
Pramipexole—Thrombocytopenia—Methotrexate—muscle cancer	0.000528	0.000547	CcSEcCtD
Pramipexole—Agitation—Doxorubicin—muscle cancer	0.000526	0.000545	CcSEcCtD
Pramipexole—Skin disorder—Methotrexate—muscle cancer	0.000524	0.000543	CcSEcCtD
Pramipexole—Hyperhidrosis—Methotrexate—muscle cancer	0.000522	0.00054	CcSEcCtD
Pramipexole—Malaise—Doxorubicin—muscle cancer	0.000516	0.000535	CcSEcCtD
Pramipexole—Vertigo—Doxorubicin—muscle cancer	0.000514	0.000533	CcSEcCtD
Pramipexole—Anorexia—Methotrexate—muscle cancer	0.000514	0.000533	CcSEcCtD
Pramipexole—Syncope—Doxorubicin—muscle cancer	0.000513	0.000532	CcSEcCtD
Pramipexole—Leukopenia—Doxorubicin—muscle cancer	0.000513	0.000531	CcSEcCtD
Pramipexole—Palpitations—Doxorubicin—muscle cancer	0.000506	0.000524	CcSEcCtD
Pramipexole—Hypotension—Methotrexate—muscle cancer	0.000504	0.000522	CcSEcCtD
Pramipexole—ADRA2A—vagina—muscle cancer	0.000503	0.0146	CbGeAlD
Pramipexole—Loss of consciousness—Doxorubicin—muscle cancer	0.000503	0.000521	CcSEcCtD
Pramipexole—Cough—Doxorubicin—muscle cancer	0.0005	0.000517	CcSEcCtD
Pramipexole—Convulsion—Doxorubicin—muscle cancer	0.000496	0.000514	CcSEcCtD
Pramipexole—Hypertension—Doxorubicin—muscle cancer	0.000494	0.000512	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000492	0.000509	CcSEcCtD
Pramipexole—Insomnia—Methotrexate—muscle cancer	0.000488	0.000506	CcSEcCtD
Pramipexole—Myalgia—Doxorubicin—muscle cancer	0.000487	0.000505	CcSEcCtD
Pramipexole—Chest pain—Doxorubicin—muscle cancer	0.000487	0.000505	CcSEcCtD
Pramipexole—Arthralgia—Doxorubicin—muscle cancer	0.000487	0.000505	CcSEcCtD
Pramipexole—Anxiety—Doxorubicin—muscle cancer	0.000486	0.000503	CcSEcCtD
Pramipexole—Paraesthesia—Methotrexate—muscle cancer	0.000485	0.000502	CcSEcCtD
Pramipexole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000484	0.000501	CcSEcCtD
Pramipexole—Discomfort—Doxorubicin—muscle cancer	0.000482	0.000499	CcSEcCtD
Pramipexole—Dyspnoea—Methotrexate—muscle cancer	0.000481	0.000498	CcSEcCtD
Pramipexole—Somnolence—Methotrexate—muscle cancer	0.00048	0.000497	CcSEcCtD
Pramipexole—Dry mouth—Doxorubicin—muscle cancer	0.000477	0.000494	CcSEcCtD
Pramipexole—Dyspepsia—Methotrexate—muscle cancer	0.000475	0.000492	CcSEcCtD
Pramipexole—Confusional state—Doxorubicin—muscle cancer	0.000471	0.000488	CcSEcCtD
Pramipexole—Decreased appetite—Methotrexate—muscle cancer	0.000469	0.000486	CcSEcCtD
Pramipexole—Oedema—Doxorubicin—muscle cancer	0.000467	0.000484	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000466	0.000483	CcSEcCtD
Pramipexole—Fatigue—Methotrexate—muscle cancer	0.000465	0.000482	CcSEcCtD
Pramipexole—ADRA2A—head—muscle cancer	0.000465	0.0135	CbGeAlD
Pramipexole—Infection—Doxorubicin—muscle cancer	0.000464	0.000481	CcSEcCtD
Pramipexole—Pain—Methotrexate—muscle cancer	0.000461	0.000478	CcSEcCtD
Pramipexole—HTR2A—tendon—muscle cancer	0.000461	0.0134	CbGeAlD
Pramipexole—Shock—Doxorubicin—muscle cancer	0.00046	0.000476	CcSEcCtD
Pramipexole—Nervous system disorder—Doxorubicin—muscle cancer	0.000458	0.000475	CcSEcCtD
Pramipexole—Thrombocytopenia—Doxorubicin—muscle cancer	0.000458	0.000474	CcSEcCtD
Pramipexole—Tachycardia—Doxorubicin—muscle cancer	0.000456	0.000472	CcSEcCtD
Pramipexole—Skin disorder—Doxorubicin—muscle cancer	0.000454	0.00047	CcSEcCtD
Pramipexole—Hyperhidrosis—Doxorubicin—muscle cancer	0.000452	0.000468	CcSEcCtD
Pramipexole—ADRA2A—testis—muscle cancer	0.000449	0.013	CbGeAlD
Pramipexole—Anorexia—Doxorubicin—muscle cancer	0.000445	0.000461	CcSEcCtD
Pramipexole—Feeling abnormal—Methotrexate—muscle cancer	0.000445	0.000461	CcSEcCtD
Pramipexole—Gastrointestinal pain—Methotrexate—muscle cancer	0.000441	0.000457	CcSEcCtD
Pramipexole—Hypotension—Doxorubicin—muscle cancer	0.000437	0.000452	CcSEcCtD
Pramipexole—Urticaria—Methotrexate—muscle cancer	0.000429	0.000444	CcSEcCtD
Pramipexole—HTR2A—vagina—muscle cancer	0.000428	0.0124	CbGeAlD
Pramipexole—Body temperature increased—Methotrexate—muscle cancer	0.000427	0.000442	CcSEcCtD
Pramipexole—Abdominal pain—Methotrexate—muscle cancer	0.000427	0.000442	CcSEcCtD
Pramipexole—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000426	0.000441	CcSEcCtD
Pramipexole—Insomnia—Doxorubicin—muscle cancer	0.000423	0.000438	CcSEcCtD
Pramipexole—Paraesthesia—Doxorubicin—muscle cancer	0.00042	0.000435	CcSEcCtD
Pramipexole—Dyspnoea—Doxorubicin—muscle cancer	0.000417	0.000431	CcSEcCtD
Pramipexole—Somnolence—Doxorubicin—muscle cancer	0.000415	0.00043	CcSEcCtD
Pramipexole—Dyspepsia—Doxorubicin—muscle cancer	0.000411	0.000426	CcSEcCtD
Pramipexole—Decreased appetite—Doxorubicin—muscle cancer	0.000406	0.000421	CcSEcCtD
Pramipexole—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000403	0.000418	CcSEcCtD
Pramipexole—Fatigue—Doxorubicin—muscle cancer	0.000403	0.000417	CcSEcCtD
Pramipexole—Constipation—Doxorubicin—muscle cancer	0.0004	0.000414	CcSEcCtD
Pramipexole—Pain—Doxorubicin—muscle cancer	0.0004	0.000414	CcSEcCtD
Pramipexole—Hypersensitivity—Methotrexate—muscle cancer	0.000398	0.000412	CcSEcCtD
Pramipexole—HTR2A—head—muscle cancer	0.000395	0.0115	CbGeAlD
Pramipexole—Asthenia—Methotrexate—muscle cancer	0.000387	0.000401	CcSEcCtD
Pramipexole—Feeling abnormal—Doxorubicin—muscle cancer	0.000385	0.000399	CcSEcCtD
Pramipexole—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000382	0.000396	CcSEcCtD
Pramipexole—HTR2A—testis—muscle cancer	0.000382	0.0111	CbGeAlD
Pramipexole—Pruritus—Methotrexate—muscle cancer	0.000382	0.000395	CcSEcCtD
Pramipexole—Urticaria—Doxorubicin—muscle cancer	0.000371	0.000384	CcSEcCtD
Pramipexole—Body temperature increased—Doxorubicin—muscle cancer	0.000369	0.000383	CcSEcCtD
Pramipexole—Abdominal pain—Doxorubicin—muscle cancer	0.000369	0.000383	CcSEcCtD
Pramipexole—Diarrhoea—Methotrexate—muscle cancer	0.000369	0.000382	CcSEcCtD
Pramipexole—Dizziness—Methotrexate—muscle cancer	0.000357	0.00037	CcSEcCtD
Pramipexole—Hypersensitivity—Doxorubicin—muscle cancer	0.000344	0.000357	CcSEcCtD
Pramipexole—Vomiting—Methotrexate—muscle cancer	0.000343	0.000355	CcSEcCtD
Pramipexole—Rash—Methotrexate—muscle cancer	0.00034	0.000352	CcSEcCtD
Pramipexole—Dermatitis—Methotrexate—muscle cancer	0.00034	0.000352	CcSEcCtD
Pramipexole—Headache—Methotrexate—muscle cancer	0.000338	0.00035	CcSEcCtD
Pramipexole—Asthenia—Doxorubicin—muscle cancer	0.000335	0.000347	CcSEcCtD
Pramipexole—Pruritus—Doxorubicin—muscle cancer	0.000331	0.000342	CcSEcCtD
Pramipexole—Nausea—Methotrexate—muscle cancer	0.000321	0.000332	CcSEcCtD
Pramipexole—Diarrhoea—Doxorubicin—muscle cancer	0.00032	0.000331	CcSEcCtD
Pramipexole—Dizziness—Doxorubicin—muscle cancer	0.000309	0.00032	CcSEcCtD
Pramipexole—Vomiting—Doxorubicin—muscle cancer	0.000297	0.000308	CcSEcCtD
Pramipexole—Rash—Doxorubicin—muscle cancer	0.000295	0.000305	CcSEcCtD
Pramipexole—Dermatitis—Doxorubicin—muscle cancer	0.000294	0.000305	CcSEcCtD
Pramipexole—Headache—Doxorubicin—muscle cancer	0.000293	0.000303	CcSEcCtD
Pramipexole—Nausea—Doxorubicin—muscle cancer	0.000278	0.000287	CcSEcCtD
